Morgan, Lewis & Bockius LLP (CEO Jami McKeon) participated in ‘BIO KOREA 5’ held at COEX in Seoul for 10 days from Wednesday, May 12th to Friday, May 3th. .
Morgan, Lewis & Bockius LLP is a global law firm with approximately 30 legal experts working in more than 2,200 branches around the world, including in Asia, North America, Europe, and the Middle East. Since its founding in 1873, it has been considered one of the largest law firms in the world.
A variety of clients in the life sciences field including mergers and acquisitions, licensing, joint ventures, intercompany transactions and fraud, abuse, product liability, intellectual property infringement and outsourcing, employment and regulatory compliance, as well as research and regulatory issues for innovative and start-up companies. Take charge of the problem. Life science-related deals concluded so far range from startup investments to company establishments, international M&A agreements to collaborations between Fortune 100 companies.
The life sciences team, dedicated to the firm’s comprehensive, cross-cutting practice, is comprised of more than 250 global partners and counsel, more than 60 of whom are highly trained scientific experts. It collaborates from offices spanning Asia, North America, Europe and the Middle East, and includes additional resources from networks in Latin America and Africa. He is said to have the ability to advise life science companies regardless of location and handle a variety of issues.
Lawyers specializing in life sciences participated in this exhibition, and among them, experts with experience serving Asian clients, including Janice Logan, a Korean-speaking lawyer, and Lesli Ligorner, a partner specializing in labor and employment in China, were introduced and attracted attention.
Morgan, Lewis & Bockius LLP emphasized that it represents Korean clients in resolving international issues, including mergers and acquisitions, limited partnerships, strategic investments and commercial contract transactions, intellectual property, and litigation. The firm has members who are familiar with the local situation through their experience working at a Korean law firm, and regularly cooperates with legal institutions in the U.S. and around the world to defend Korean clients.
Accordingly, a law firm official said, “Our dedicated life sciences team is well-versed in the numerous legal, commercial, and cross-cultural issues that arise as Korean companies expand their scope of activities overseas. “We also support the process for companies from overseas, including the United States, to enter the Korean market,” he explained.
Main services focus on helping Korean customers facing complex business transactions, connecting investment banks and venture capital communities in global economic districts such as the United States, London, Singapore, and Dubai, and providing criminal prosecution, counseling, antitrust and other services related to outstanding intellectual property rights. We provide audit, investigation, and prosecution service.
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th anniversary this year, was hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. BIO KOREA, which has been striving to improve the global status and sustainable growth of the Korean health industry since 2006, is solidifying its position as Korea’s representative biohealth international convention with the participation of world-class scholars and business experts every year. BIO KOREA 2023, in collaboration with companies related to the health industry such as domestic and foreign bio, pharmaceuticals, medical devices, cosmetics, and food, as well as interested companies and institutions such as consulting, academia, and related organizations, will be held through various programs such as conferences, business partnering, exhibitions, and investment fairs. It went ahead.